sCD14 levels at various stages of TB infection and during therapy.

<p>Soluble CD14 concentrations (ng/ml) in plasma from A) patients with LTBI (n = 6) and active TB (n = 19) at baseline and after 8 and 24 weeks of anti-TB therapy and B) active TB (n = 10) at baseline and after 2 weeks of anti-TB therapy. Horizontal lines represent the median values. Significant p values (<.05) between groups and time-points are indicated.